COVID-19 transmission graph

Coronavirus: WHO declares COVID 19 a pandemic. Prevention | FAQs | COVID-19 portal

URGENT:COVID prophylaxis | Vitamin D | Latest research | NIH | CDC | Worldometer

NB:Did you know one coronavirus patient can infect 59,000 others if nothing is done? Dietary cholesterol may not raise cardiovascular risk! Ketogenic diet

Progressive supranuclear palsy

From WikiMD
Jump to navigation Jump to search

Lua error in package.lua at line 80: module 'Module:Category handler' not found.

Progressive supranuclear palsy (PSP), also known as Steele–Richardson–Olszewski syndrome, is a degenerative disease involving the gradual deterioration and death of specific volumes of the brain.[1] The condition leads to symptoms including loss of balance, slowing of movement, difficulty moving the eyes, and dementia.[1] PSP may be mistaken for other neurodegenerative diseases such as Parkinson's and Alzheimer's. The cause of the condition is uncertain, but involves accumulation of tau protein within the brain. Medications such as levodopa and amantadine may be useful in some cases.[1]

PSP affects about six people per 100,000.[1] The first symptoms typically occur in persons aged 60–70 years. Males are slightly more likely to be affected than females.[1] No association has been found between PSP and any particular race, location, or occupation.[1]

Symptoms and signs

This patient presented with progressive dementia, ataxia, and incontinence. A clinical diagnosis of normal-pressure hydrocephalus was entertained. Imaging did not support this, however, and on formal testing, abnormal nystagmus and eye movements were detected. A sagittal view of the CT/MRI scan shows atrophy of the midbrain, with preservation of the volume of the pons. This appearance has been called the "hummingbird sign" or "penguin sign". Also, atrophy of the tectum is seen, particularly the superior colliculi. These findings suggest the diagnosis of progressive supranuclear palsy.[2]

The initial symptoms in two-thirds of cases are loss of balance, lunging forward when mobilizing, fast walking, bumping into objects or people, and falls.Script error: No such module "Category handler".Script error: No such module "Category handler".[citation needed] Dementia symptoms are also initially seen in about one in five cases.[3]

Other common early symptoms are changes in personality, general slowing of movement, and visual symptoms.

Later symptoms and signs are dementia (typically including loss of inhibition and ability to organize information), slurring of speech, difficulty swallowing, and difficulty moving the eyes, particularly in the vertical direction. The latter accounts for some of the falls experienced by these patients, as they are unable to look up or down.

Some of the other signs are poor eyelid function, contracture of the facial muscles, a backward tilt of the head with stiffening of the neck muscles, sleep disruption, urinary incontinence, and constipation.

The visual symptoms are of particular importance in the diagnosis of this disorder. Patients typically complain of difficulty reading due to the inability to look down well. Notably, the ophthalmoparesis experienced by these patients mainly concerns voluntary eye movement and the inability to make vertical saccades, which is often worse with downward saccades. Patients tend to have difficulty looking down (a downgaze palsy) followed by the addition of an upgaze palsy. This vertical gaze paresis will correct when the examiner passively rolls the patient's head up and down as part of a test for the oculocephalic reflex. Involuntary eye movement, as elicited by Bell's phenomenon, for instance, may be closer to normal. On close inspection, eye movements called "square-wave jerks" may be visible when the patient fixes at distance. These are fine movements, that can be mistaken for nystagmus, except that they are saccadic in nature, with no smooth phase. Although healthy individuals also make square-wave jerk movements, PSP patients make slower square-wave jerk movements, with smaller vertical components.[4] Assessment of these square-wave jerks and diminished vertical saccades is especially useful for diagnosing progressive supranuclear palsy, because these movements set PSP patients apart from other parkinsonian patients.[4] Difficulties with convergence (convergence insufficiency), where the eyes come closer together while focusing on something near, like the pages of a book, is typical. Because the eyes have trouble coming together to focus at short distances, the patient may complain of diplopia (double vision) when reading.

Cardinal manifestations:

Cause

The cause of PSP is unknown. Fewer than 1% of those with PSP have a family member with the same disorder. A variant in the gene for tau protein called the H1 haplotype, located on chromosome 17, has been linked to PSP.[5] Nearly all people with PSP received a copy of that variant from each parent, but this is true of about two-thirds of the general population. Therefore, the H1 haplotype appears to be necessary but not sufficient to cause PSP. Other genes, as well as environmental toxins, are being investigated as other possible contributors to the cause of PSP. Especially, mitochondrial complex I inhibitors (such as acetogenins, quinolines, and rotenoids) are implicated in PSP-like brain injuries.[6]

Pathophysiology

The affected brain cells are both neurons and glial cells. The neurons display neurofibrillary tangles (NFTs), which are clumps of tau protein, a normal part of a brain cell's internal structural skeleton. These tangles are often different from those seen in Alzheimer's disease, but may be structurally similar when they occur in the cerebral cortex.[7] Their chemical composition is usually different, however, and is similar to that of tangles seen in corticobasal degeneration.[8] Tufts of tau protein in astrocytes, or tufted astrocytes, are also considered diagnostic. Unlike globose NFTs, they may be more widespread in the cortex.[9] Lewy bodies are seen in some cases, but whether this is a variant or an independent co-existing process is not clear, and in some cases, PSP can coexist with corticobasal degeneration, Parkinson's, and/or Alzheimer's disease, particularly with older patients.[10][11][12][13][14]

The principal areas of the brain affected are the:

Some consider PSP, corticobasal degeneration, and frontotemporal dementia to be variations of the same disease.[15][16] Others consider them separate diseases.[17][18][19] PSP has been shown occasionally to co-exist with Pick's disease.[20]

Diagnosis

MRI is often done to diagnose PSP. MRI may show atrophy in the midbrain with preservation of the pons giving a "hummingbird" sign appearance and Mickey Mouse sign[21]

Differential diagnosis

PSP is frequently misdiagnosed as Parkinson's disease because they both involve slowed movements and gait difficulty, with PSP being one of a collection of diseases referred to as Parkinson plus syndromes. Both Parkinson's and PSP have an onset in late middle age and involve slowing and rigidity of movement. However, several distinguishing features exist. Tremor is very common with Parkinson's, but rare with PSP. Speech and swallowing difficulties are more common and severe with PSP and the abnormal eye movements of PSP are essentially absent with PD.[22] A poor response to levodopa along with symmetrical onset can also help differentiate PSP from PD.[23] Patients with the Richardson variant of PSP tend to have an upright posture or arched back, as opposed to the stooped-forward posture of other Parkinsonian disorders, although PSP-Parkinsonism (see below) can demonstrate a stooped posture.[24] Early falls are also more common with PSP, especially with Richardson syndrome.[25]

PSP can also be misdiagnosed as Alzheimer's disease because of the behavioral changes.Script error: No such module "Category handler".Script error: No such module "Category handler".[citation needed]

Chronic traumatic encephalopathy shows many similarities with PSP.

Treatment

No cure for PSP is known, and management is primarily supportive. PSP cases are often split into two subgroups, PSP-Richardson, the classic type, and PSP-Parkinsonism, where a short-term response to levodopa can be obtained.[26] Dyskinesia is an occasional but rare complication of treatment.[27] Amantadine is also sometimes helpful.[28] After a few years the Parkinsonian variant tends to take on Richardson features.[29] Other variants have been described.[30][31][32][33] Botox can be used to treat neck dystonia and blepharospasm, but this can aggravate dysphagia.[34]

Two studies have suggested that rivastigmine may help with cognitive aspects, but the authors of both studies have suggested a larger sampling be used.[35][36] There is some evidence that the hypnotic zolpidem may improve motor function and eye movements, but only from small-scale studies.[37][38]

Rehabilitation

Patients with PSP usually seek or are referred to occupational therapy, speech-language pathology for motor speech changes typically a spastic-ataxic dysarthria, and physical therapy for balance and gait problems with reports of frequent falls.[39] Evidence-based approaches to rehabilitation in PSP are lacking, and currently, the majority of research on the subject consists of case reports involving only a small number of patients.

Case reports of rehabilitation programs for patients with PSP generally include limb-coordination activities, tilt-board balancing, gait training, strength training with progressive resistive exercises, and isokinetic exercises and stretching of the neck muscles.[39] While some case reports suggest that physiotherapy can offer improvements in balance and gait of patients with PSP, the results cannot be generalized across all PSP patients, as each case report only followed one or two patients.[39] The observations made from these case studies can be useful, however, in helping to guide future research concerning the effectiveness of balance and gait training programs in the management of PSP.

Individuals with PSP are often referred to occupational therapists to help manage their condition and to help enhance their independence. This may include being taught to use mobility aids.[40][41] Due to their tendency to fall backwards, the use of a walker, particularly one that can be weighted in the front, is recommended over a cane.[40] The use of an appropriate mobility aid helps to decrease the individual’s risk of falls and makes them safer to ambulate independently in the community.[41] Due to their balance problems and irregular movements, individuals need to spend time learning how to safely transfer in their homes and in the community.[40] This may include rising from and sitting in chairs safely.[41]

Due to the progressive nature of this disease, all individuals eventually lose their ability to walk and will need to progress to using a wheelchair.[40] Severe dysphagia often follows, and at this point death is often a matter of months.[26]

Prognosis

Currently, no effective treatment or cure has been found for PSP, although some of the symptoms can respond to nonspecific measures. The average age at symptoms onset is 63 and survival from onset averages 7 years with a wide variance. Pneumonia is a frequent cause of death.[42]

History

Progressive supranuclear palsy was first described by neurologists John Steele, John Richardson, and Jerzy Olszewski in 1963.[1][43][44]

Societies

Internationally, several organizations serve the needs of patients with PSP and their families and support research.

  • Canada: With the help of the CurePSP Association based in the United States, since 2014-2015, plans have been made for Canada to have its own CUREPSP organization, and in 2018, this reached fruition.[45][46]
  • France: PSP-France association, based in Paris[47]
  • UK: PSP Association[48]
  • US: The Foundation for PSP, CBD and Related Brain Diseases[49]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Script error: No such module "Citation/CS1".
  2. Script error: No such module "Citation/CS1".
  3. Script error: No such module "Citation/CS1".
  4. 4.0 4.1 Script error: No such module "Citation/CS1".
  5. Online Mendelian Inheritance in Man (OMIM) 601104
  6. Script error: No such module "Citation/CS1".
  7. Script error: No such module "Citation/CS1".
  8. Script error: No such module "Citation/CS1".
  9. Script error: No such module "Citation/CS1".
  10. Script error: No such module "Citation/CS1".
  11. Script error: No such module "Citation/CS1".
  12. Script error: No such module "Citation/CS1".
  13. Script error: No such module "Citation/CS1".
  14. Script error: No such module "Citation/CS1".
  15. Script error: No such module "Citation/CS1".
  16. Script error: No such module "Citation/CS1".
  17. Script error: No such module "Citation/CS1".
  18. Script error: No such module "Citation/CS1".
  19. Script error: No such module "Citation/CS1".
  20. Script error: No such module "Citation/CS1".
  21. Script error: No such module "Citation/CS1".
  22. Script error: No such module "citation/CS1".
  23. Script error: No such module "Citation/CS1".
  24. Script error: No such module "Citation/CS1".
  25. 26.0 26.1 Script error: No such module "Citation/CS1".
  26. Script error: No such module "Citation/CS1".
  27. Script error: No such module "Citation/CS1".
  28. Script error: No such module "citation/CS1".
  29. Script error: No such module "citation/CS1".
  30. Script error: No such module "citation/CS1".
  31. Script error: No such module "citation/CS1".
  32. Script error: No such module "Citation/CS1".
  33. Script error: No such module "Citation/CS1".
  34. Script error: No such module "Citation/CS1".
  35. Script error: No such module "Citation/CS1".
  36. Script error: No such module "Citation/CS1".
  37. Script error: No such module "Citation/CS1".
  38. 39.0 39.1 39.2 Script error: No such module "Citation/CS1".
  39. 40.0 40.1 40.2 40.3 Script error: No such module "Citation/CS1".
  40. 41.0 41.1 41.2 Script error: No such module "Citation/CS1".
  41. Script error: No such module "Citation/CS1".
  42. Script error: No such module "Citation/CS1".
  43. Script error: No such module "Citation/CS1".
  44. The New Home For Progressive Supranuclear Palsy Information in Canada at pspsocietycanada.ca, accessed 4 November 2018
  45. About Us pspsocietycanada.ca, accessed 4 November 2018
  46. Accueil (Welcome) pspfrance.org, accessed 4 November 2018
  47. ...PSPA is a registered charity in England and Wales and in Scotland... pspassociation.org.uk, accessed 4 November 2018
  48. CurePSP, Unlocking the Secrets of Brain Disease psp.org, accessed 4 November 2018

Portions of content adapted from Wikipedias article on Progressive supranuclear palsy licensed under GNU FDL.

External links

Classification
[[d:Lua error in Module:WikidataIB at line 2616: attempt to index field 'wikibase' (a nil value). |D]]
External resources
  1. REDIRECT Template:CNS diseases of the nervous system The diseases hurt
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP*

Quick links: Medicine Portal | Encyclopedia‏‎‏‎ | Gray's Anatomy‏‎ | Topics‏‎ |‏‎ Diseases‏‎ | Drugs | Wellness | Obesity‏‎ | Metabolic syndrome | Weight loss*
Disclaimer: The entire contents of WIKIMD.ORG are for informational purposes only and do not render medical advice or professional services. If you have a medical emergency, you should CALL 911 immediately! Given the nature of the wiki, the information provided may not be accurate, misleading and or incorrect. Use the information on this wiki at your own risk! See full Disclaimer.
Link to this page: <a href="http://www.wikimd.org/wiki/Progressive_supranuclear_palsy">Progressive supranuclear palsy</a>

  • Individual results may vary for weight loss from our sponsors.